Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Redhill Biopharma Ltd (NASDAQ:RDHL)

5.21
Delayed Data
As of 3:59pm ET
 +0.02 / +0.39%
Today’s Change
4.82
Today|||52-Week Range
12.09
-50.19%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues12.0K6.9M3.0K101.3K
 
 
 
 
 
Cost of Goods Sold--1.0M0.00--
 
 
Depreciation And Amortization24.1K26.6K36.0K44.1K
 
 
 
 
 
 
Operating ExpensesGross Income--5.9M-33.0K--
 
 
 
General Expenses10.8M16.5M21.9M30.7M
 
 
 
 
 
Research And Development8.1M12.5M17.8M25.3M
 
 
 
 
 
Total Operating Expenses10.8M17.5M21.9M30.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-10.8M-10.6M-21.9M-30.6M
 
 
 
 
 
Extraordinary Credit54.1K197.2K887.7K1.2M
 
 
 
 
 
Extraordinary Charge0.00---100.0K-369.2K
 
 
 
Other Expenses90.2K-279.0K-211.9K27.1K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-10.7M-10.6M-21.1M-29.5M
 
 
 
 
 
Net Income-10.7M-10.6M-21.1M-29.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS6.2M8.7M11.1M12.9M
 
 
 
 
 
Shares To Calculate EPS Diluted6.2M8.7M11.2M12.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.70-$1.18-$1.90-$2.31
 
 
 
 
 
EPS Diluted-$1.70-$1.28-$1.90-$2.41